aod9604 development discontinued AOD-9604 purity research formula manufactured in the USA AOD-9604: Lessons from a discontinued
Description
Specific Evidence for No IGF-1 Effects: Blood samples collected at baseline and throughout the treatment period measured serum IGF-1 concentrations using validated immunoassays
AOD9604 is utilized in controlled laboratory research settings for applications such as: At Pure Health Peptides, transparency is key
Isoleucine: Deters muscle degradation and accentuates recovery
As of 2025, AOD-9604 should be regarded as a discontinued research peptide, not a therapeutic agent , with ongoing relevance confined to academic and mechanistic exploration
